当前位置：首页 > 文献互助 > 互助详情

期刊论文A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies复制

用户7nEFK6amBq5Y 10个月前 377 已关闭

文献链接:复制

其他信息:

互助时间线

楼主用户7nEFK6amBq5Y关闭了求助

Genomic approaches to explore susceptibility and pathogenesis of alcohol use disorder and alcohol-associated liver disease. 7小时前

Emerging Targets for the Treatment of Primary Sclerosing Cholangitis 8小时前

Primary sclerosing cholangitis 8小时前

Dose-dependent effects of zoledronic acid on the osteogenic differentiation of human bone marrow stem cells (hBMSCs) 9小时前

The complex web of canonical and non‐canonical Hedgehog signaling 10小时前

Carbonaceous materials in structural dimensions for advanced oxidation processes 10小时前

Research progress on the Sonic Hedgehog signaling pathway in the central nervous system: Novel insights 10小时前

Epigenetic evolution of isocitrate dehydrogenase-wildtype glioblastomas 11小时前

Metal Nanoparticle Effects on Halomonas campaniensis XH26 and Metabolomics Analysis under Fe3O4 NPs Stress 11小时前

Discovery of INCB191358: A Potent and Selective DGKα/ζ Dual Inhibitor 17小时前